Quinestradol
| Quinestradol | |
|---|---|
| Quinestradiol_structure.png | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Quinestradol is a synthetic estrogen that was developed for medical use. It is a derivative of estradiol, the primary female sex hormone, and is used in hormone replacement therapy and other estrogen-related treatments.
Chemical Structure[edit]
Quinestradol is a steroidal estrogen, meaning it is based on the steroid structure of estradiol. It is chemically known as 3-cyclopentyl ether of estradiol. The presence of the cyclopentyl group in its structure makes it a unique compound among estrogens.
Pharmacology[edit]
Quinestradol acts as an agonist of the estrogen receptor, which is the biological target of estrogens like estradiol. By binding to these receptors, quinestradol mimics the effects of natural estrogens in the body, influencing the development and maintenance of female reproductive tissues and secondary sexual characteristics.
Medical Uses[edit]
Quinestradol has been used in the treatment of menopausal symptoms, such as hot flashes, vaginal atrophy, and osteoporosis. It is also used in hormone replacement therapy for women who have undergone oophorectomy or have hypoestrogenism.
Administration[edit]
Quinestradol is typically administered orally. The dosage and duration of treatment depend on the specific condition being treated and the patient's response to the therapy.
Side Effects[edit]
As with other estrogens, quinestradol can cause side effects such as nausea, breast tenderness, headache, and fluid retention. Long-term use of estrogens has been associated with an increased risk of breast cancer and endometrial cancer.
Related Compounds[edit]
Quinestradol is related to other synthetic estrogens such as ethinylestradiol and mestranol. These compounds are also used in various hormonal therapies and oral contraceptives.
History[edit]
Quinestradol was developed in the mid-20th century as part of efforts to create effective synthetic estrogens for therapeutic use. It was one of several compounds explored for its potential benefits in hormone therapy.
See Also[edit]
Related Pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
